Pricing Log in Create free account

Microbot Medical Inc. (MBOT) vs Sera Prognostics, Inc. (SERA)

Microbot Medical Inc. and Sera Prognostics, Inc. are both Medical Devices companies. Sera Prognostics, Inc. is the larger, with a market value of $82.1M against $71.9M — 1.1× the size. Sera Prognostics, Inc. grew revenue faster over the last twelve months: 1.05% against −59.1%. Microbot Medical Inc. has the higher net margin (−3,955.2% vs −34,866.7%) and the lower return on invested capital (−850.5% vs −278.6%). Across the 17 metrics below, Microbot Medical Inc. leads on 12 and Sera Prognostics, Inc. on 5.

Valuation

Metric MBOT SERA Medical Devices median
P/E n/m n/m 25.58
P/S 172.34 1,100.45 2.54
P/B 1.03 2.01 2.48
Price to free cash flow n/m n/m 28.81
EV/EBITDA n/m n/m 11.51
EV/Sales 15.01 641.21 2.72
Earnings yield (22.64%) (32.21%) (12.82%)
Free cash flow yield (25.18%) (27.81%) (8.18%)

Profitability

Metric MBOT SERA Medical Devices median
Gross margin (166.30%) 0.00% 57.76%
Operating margin (4,480.03%) (38,755.21%) (15.07%)
Net margin (3,955.22%) (34,866.67%) (14.45%)
Free cash flow margin (4,340.11%) (30,198.96%) (3.88%)
Return on equity (32.91%) (49.73%) (10.35%)
Return on assets (30.68%) (35.59%) (17.26%)
Return on invested capital (850.51%) (278.58%) (5.27%)

Growth

Metric MBOT SERA Medical Devices median
Revenue growth (TTM) (59.09%) 1.05% 10.41%
EPS growth (last fiscal year) 60.27% 32.32% 28.17%
Revenue growth, 5-year CAGR 0.39% 26.51% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MBOT SERA Medical Devices median
Debt to equity 0.00 0.00 0.04
Current ratio 18.56 1.88 2.74
Net debt to EBITDA 5.35 1.10 0.54

Dividend

Metric MBOT SERA Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric MBOT SERA Medical Devices median
Market cap 71.87m 82.05m 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack